Stanate
64,185-06-2W
Phase 2 small_molecule completed
Quick answer
Stanate for Hyperbilirubinemia is a Phase 2 program (small_molecule) at Mallinckrodt Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mallinckrodt Pharmaceuticals Ireland Limited
- Indication
- Hyperbilirubinemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed